About Medifast (NYSE:MED)
Medifast, Inc. produces, distributes and sells weight loss, weight management, and healthy living products, and other consumable health and nutritional products. The Company's product lines include weight loss, weight management, and healthy living meal replacements, snacks, hydration products, and vitamins. Its business units include Optavia, Medifast Direct, Franchise Medifast Weight Control Centers (MWCC) and Medifast Wholesale. Optavia is a personal coaching division of the Company that consists of Optavia Coaches, who provides coaching and support to clients utilizing the Optavia platform. Medifast Direct is its direct-to-consumer business unit that allows customers to order Medifast products directly through its Website or its in-house call center. The MWCC business unit sells product through franchise and reseller locations, which offers structured programs and a team of professionals to help customers achieve weight-loss and weight-management success at center locations.
Industry, Sector and Symbol
Trailing P/E Ratio39.7163306389984
Forward P/E Ratio27.98
Sales & Book Value
Annual Sales$301.56 million
Price / Sales3.60
Cash Flow$2.76 per share
Price / Cash32.91
Book Value$9.10 per share
Price / Book9.99
Net Income$27.72 million
Return on Equity26.39%
Return on Assets20.81%
Medifast (NYSE:MED) Frequently Asked Questions
What is Medifast's stock symbol?
Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."
How often does Medifast pay dividends? What is the dividend yield for Medifast?
Medifast declared a quarterly dividend on Friday, March 16th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.48 per share on Tuesday, May 8th. This represents a $1.92 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend is Wednesday, March 28th. View Medifast's Dividend History.
How were Medifast's earnings last quarter?
Medifast Inc (NYSE:MED) released its quarterly earnings data on Tuesday, March, 6th. The specialty retailer reported $0.60 EPS for the quarter, beating analysts' consensus estimates of $0.48 by $0.12. The specialty retailer had revenue of $78.01 million for the quarter, compared to the consensus estimate of $73.48 million. Medifast had a net margin of 9.19% and a return on equity of 26.39%. The business's revenue for the quarter was up 24.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.34 EPS. View Medifast's Earnings History.
When will Medifast make its next earnings announcement?
What guidance has Medifast issued on next quarter's earnings?
Medifast issued an update on its FY18 earnings guidance on Tuesday, March, 6th. The company provided EPS guidance of $3.15-3.25 for the period, compared to the Thomson Reuters consensus estimate of $2.56. The company issued revenue guidance of $350-360 million, compared to the consensus revenue estimate of $330.80 million.Medifast also updated its Q1 guidance to $0.84-0.87 EPS.
Where is Medifast's stock going? Where will Medifast's stock price be in 2018?
2 analysts have issued 1 year price targets for Medifast's stock. Their predictions range from $55.00 to $108.00. On average, they expect Medifast's stock price to reach $81.50 in the next twelve months. View Analyst Ratings for Medifast.
Who are some of Medifast's key competitors?
Some companies that are related to Medifast include Tootsie Roll Industries (TR), Hostess Brands (TWNK), B&G Foods (BGS), Calavo Growers (CVGW), Greencore Group (GNCGY), MGP Ingredients (MGPI), Cresud S.A.C.I.F. y A. (CRESY), Adecoagro (AGRO), Simply Good Foods (SMPL), Dean Foods (DF), Chefs' Warehouse (CHEF), John B. Sanfilippo & Son (JBSS), SunOpta (STKL), Freshpet (FRPT), Supervalu (SVU), Calyxt (CLXT), Smart & Final Stores (SFS) and Premier Foods (PRRFY).
Who are Medifast's key executives?
Medifast's management team includes the folowing people:
- Daniel R. Chard, Chief Executive Officer, Director (Age 52)
- Timothy G. Robinson CPA, Chief Financial Officer (Age 52)
- Jason L. Groves Esq., Executive Vice President, General Counsel (Age 46)
- Jeanne M. City, Executive Vice President - Human Resources (Age 57)
- Joseph P. Kelleman, Vice President - Finance, Corporate Controller (Age 62)
- Michael Charles MacDonald, Non-Executive Chairman of the Board (Age 64)
- Jeffrey J. Brown, Lead Independent Director (Age 56)
- Constance J. Hallquist, Director (Age 53)
- Kevin G. Byrnes, Independent Director (Age 69)
- Charles P. Connolly, Independent Director (Age 68)
Has Medifast been receiving favorable news coverage?
Headlines about MED stock have been trending positive recently, Accern Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Medifast earned a news impact score of 0.27 on Accern's scale. They also assigned news coverage about the specialty retailer an impact score of 46.00 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near future.
Who are Medifast's major shareholders?
Medifast's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.28%), Acadian Asset Management LLC (3.84%), American Century Companies Inc. (2.46%), Arrowstreet Capital Limited Partnership (1.59%), Geode Capital Management LLC (1.57%) and Bank of New York Mellon Corp (1.49%). Company insiders that own Medifast stock include Balanced Master Fund L Visium, Charles P Connolly, Glenn W Welling, Jeffrey J Brown, Jeremy John Martin, Margaret Sheetz, Michael C Macdonald, Ralph Rushton and Simon TP Ridgway. View Institutional Ownership Trends for Medifast.
Which major investors are selling Medifast stock?
MED stock was sold by a variety of institutional investors in the last quarter, including Kennedy Capital Management Inc., Bank of New York Mellon Corp, Spark Investment Management LLC, Chickasaw Capital Management LLC, Ingalls & Snyder LLC, Schroder Investment Management Group, Martingale Asset Management L P and American Century Companies Inc.. Company insiders that have sold Medifast company stock in the last year include Charles P Connolly, Glenn W Welling, Jeremy John Martin, Michael C Macdonald and Ralph Rushton. View Insider Buying and Selling for Medifast.
Which major investors are buying Medifast stock?
MED stock was purchased by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., BlackRock Inc., WINTON GROUP Ltd, Arrowstreet Capital Limited Partnership, HL Financial Services LLC, Geode Capital Management LLC, Driehaus Capital Management LLC and Assenagon Asset Management S.A.. Company insiders that have bought Medifast stock in the last two years include Glenn W Welling, Jeffrey J Brown and Simon TP Ridgway. View Insider Buying and Selling for Medifast.
How do I buy shares of Medifast?
Shares of MED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medifast's stock price today?
One share of MED stock can currently be purchased for approximately $90.95.
How big of a company is Medifast?
Medifast has a market capitalization of $1.07 billion and generates $301.56 million in revenue each year. The specialty retailer earns $27.72 million in net income (profit) each year or $2.29 on an earnings per share basis. Medifast employs 422 workers across the globe.
How can I contact Medifast?
Medifast's mailing address is 100 International Drive, Baltimore MD, 21201. The specialty retailer can be reached via phone at 410-581-8042 or via email at [email protected]
MarketBeat Community Rating for Medifast (MED)MarketBeat's community ratings are surveys of what our community members think about Medifast and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Medifast (NYSE:MED) Earnings History and Estimates Chart
Medifast (NYSE MED) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/3/2018|| || || || || || || || |
|3/6/2018||Q4 2017||$0.48||$0.60||$73.48 million||$78.01 million||View||Listen|
|11/7/2017||Q3 2017||$0.51||$0.55||$74.94 million||$77.20 million||View||N/A|
|8/8/2017||Q2 2017||$0.53||$0.63||$71.96 million||$75.70 million||View||Listen|
|5/4/2017||Q1 2017||$0.49||$0.51||$72.36 million||$70.62 million||View||Listen|
|3/9/2017||Q4 2016||$0.33||$0.34||$65.01 million||$62.50 million||View||Listen|
|11/3/2016||Q316||$0.45||$0.51||$66.79 million||$68.57 million||View||N/A|
|8/3/2016||Q216||$0.51||$0.63||$72.01 million||$71.14 million||View||N/A|
|5/4/2016||Q116||$0.33||$0.42||$69.31 million||$72.30 million||View||N/A|
|3/10/2016||Q415||$0.35||$0.33||$62.98 million||$61.30 million||View||Listen|
|11/5/2015||Q315||$0.42||$0.45||$67.00 million||$65.90 million||View||N/A|
|8/5/2015||Q215||$0.48||$0.48||$72.79 million||$72.20 million||View||N/A|
|5/7/2015||Q115||$0.35||$0.46||$71.80 million||$73.30 million||View||N/A|
|3/12/2015||Q414||$0.46||$0.38||$69.40 million||$62.30 million||View||N/A|
|11/5/2014||Q314||$0.36||$0.47||$76.10 million||$74.00 million||View||N/A|
|8/7/2014||Q114||$0.40||$0.44||$87.30 million||$80.88 million||View||N/A|
|5/5/2014||Q1||$0.37||$0.45||$87.60 million||$86.50 million||View||N/A|
|3/10/2014||Q413||$0.36||$0.39||$80.83 million||$77.30 million||View||N/A|
|11/5/2013||Q313||$0.42||$0.41||$95.07 million||$86.48 million||View||N/A|
|8/6/2013||Q2 2013||$0.51||$0.51||$101.30 million||$97.10 million||View||N/A|
|5/8/2013||Q1 2013||$0.34||$0.43||$93.77 million||$96.00 million||View||N/A|
|3/7/2013||Q4 2012||$0.25||$0.28||$82.90 million||$83.20 million||View||N/A|
|11/5/2012||Q312||$0.40||$0.42||$89.73 million||$91.00 million||View||N/A|
Medifast (NYSE:MED) Earnings Estimates
2018 EPS Consensus Estimate: $3.25
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Medifast (NYSE:MED) Dividend Information
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||83.84% (Trailing 12 Months of Earnings) |
59.08% (Based on This Year's Estimates)
48.00% (Based on Next Year's Estimates)
Medifast (NYSE:MED) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Medifast (NYSE MED) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 5.40%
Institutional Ownership Percentage: 88.14%
Medifast (NYSE MED) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/15/2018||Charles P Connolly||Director||Sell||7,500||$89.31||$669,825.00||40,342|| |
|3/8/2018||Michael C Macdonald||Director||Sell||20,000||$84.45||$1,689,000.00||334,188|| |
|12/1/2017||Glenn W Welling||Director||Sell||275,000||$64.60||$17,765,000.00|| |
|11/13/2017||Glenn W Welling||Director||Sell||250,000||$65.00||$16,250,000.00|| |
|9/6/2017||Jeremy John Martin||Director||Sell||131,500||$0.18||$23,670.00|
|7/7/2017||Simon T.P. Ridgway||Insider||Buy||1,500||$0.15||$225.00|
|7/5/2017||Simon T.P. Ridgway||Insider||Buy||29,000||$0.15||$4,350.00|
|3/14/2017||Glenn W Welling||Director||Buy||17,084||$41.33||$706,081.72||5,309|| |
|11/15/2016||Glenn W Welling||Director||Buy||35,000||$39.02||$1,365,700.00||2,670|| |
|11/9/2016||Jeffrey J Brown||Director||Buy||10,000||$38.71||$387,100.00||13,254|| |
|5/31/2016||Balanced Master Fund L Visium||Major Shareholder||Sell||1,350,000||$30.25||$40,837,500.00||1,247,882|| |
|4/1/2016||Margaret Sheetz||COO||Sell||8,333||$30.02||$250,156.66||327,346|| |
|2/1/2016||Margaret Sheetz||COO||Sell||8,333||$28.62||$238,490.46||336,762|| |
|12/1/2015||Margaret Sheetz||COO||Sell||8,333||$29.92||$249,323.36||353,428|| |
|11/2/2015||Margaret Sheetz||COO||Sell||8,333||$28.72||$239,323.76||361,761|| |
|10/5/2015||Margaret Sheetz||COO||Sell||8,333||$28.88||$240,657.04||370,094|| |
|9/4/2015||Simon T.P. Ridgway||Director||Buy||4,000||$0.08||$320.00|
|9/3/2015||Margaret Sheetz||COO||Sell||6,864||$28.00||$192,192.00||378,427|| |
|9/2/2015||Margaret Sheetz||COO||Sell||1,469||$28.00||$41,132.00||385,291|| |
|9/1/2015||Simon T.P. Ridgway||Director||Buy||16,000||$0.08||$1,280.00|
|8/25/2015||Simon T.P. Ridgway||Director||Buy||1,000||$0.09||$85.00|
|8/24/2015||Simon T.P. Ridgway||Director||Buy||2,000||$0.09||$180.00|
|8/19/2015||Simon T.P. Ridgway||Director||Buy||15,000||$0.10||$1,425.00|
|8/18/2015||Simon T.P. Ridgway||Director||Buy||35,000||$0.10||$3,325.00|
|8/17/2015||Radius Gold Inc.||Insider||Buy||5,000||$0.09||$450.00|
|8/14/2015||Radius Gold Inc.||Insider||Buy||35,000||$0.10||$3,500.00|
|8/14/2015||Simon T.P. Ridgway||Director||Buy||10,000||$0.10||$950.00|
|6/25/2015||Moduslink Global Solutions Inc||Major Shareholder||Sell||29,654||$33.03||$979,471.62|| |
|6/23/2015||Moduslink Global Solutions Inc||Major Shareholder||Sell||27,443||$33.01||$905,893.43|| |
|6/22/2015||Moduslink Global Solutions Inc||Major Shareholder||Sell||9,494||$33.01||$313,396.94|| |
|6/11/2015||Barry B Bondroff||Director||Sell||1,666||$31.88||$53,112.08|| |
|6/10/2015||Margaret Sheetz||COO||Sell||8,337||$32.00||$266,784.00|| |
|6/4/2015||John P Mcdaniel||Director||Sell||3,000||$32.14||$96,420.00|| |
|8/18/2014||Jeannette M Mills||EVP||Sell||3,000||$28.03||$84,090.00|| |
|6/10/2014||Jason L Groves||EVP||Sell||3,250||$31.75||$103,187.50|| |
|6/10/2014||John P Mcdaniel||Director||Sell||3,500||$31.74||$111,090.00|| |
|6/9/2014||Jeannette M Mills||EVP||Sell||2,784||$32.09||$89,338.56|| |
|6/5/2014||Charles P Connolly||Director||Sell||7,500||$30.91||$231,825.00|| |
|12/2/2013||Margaret Macdonald Sheetz||COO||Sell||18,000||$25.63||$461,340.00||351,292|| |
|11/22/2013||Margaret Macdonald Sheetz||COO||Sell||35,000||$24.33||$851,550.00||369,292|| |
Medifast (NYSE MED) News Headlines
|Medifast Inc (MED) Director Charles P. Connolly Sells 7,500 Shares|
www.americanbankingnews.com - March 19 at 7:28 PM
|Medifast Inc (MED) Announces $0.48 Quarterly Dividend|
www.americanbankingnews.com - March 16 at 5:54 PM
|Medifast, Inc. Announces Quarterly Dividend|
finance.yahoo.com - March 15 at 4:51 PM
|Medifast Inc (MED) Director Sells $1,689,000.00 in Stock|
www.americanbankingnews.com - March 13 at 10:11 PM
|5 Stocks With Recent Price Strength to Maximize Your Returns|
finance.yahoo.com - March 13 at 6:15 PM
|Medifast (MED) Upgraded to "Strong-Buy" at Zacks Investment Research|
www.americanbankingnews.com - March 10 at 6:06 AM
|Q1 2018 Earnings Forecast for Medifast Inc (MED) Issued By DA Davidson|
www.americanbankingnews.com - March 9 at 7:54 AM
|Medifast (MED) Price Target Raised to $108.00 at DA Davidson|
www.americanbankingnews.com - March 8 at 11:04 PM
|Today’s Research Reports on Stocks to Watch: Weight Watchers International and Medifast|
finance.yahoo.com - March 8 at 9:55 AM
|Q3 2018 EPS Estimates for Medifast Inc (MED) Increased by Analyst|
www.americanbankingnews.com - March 8 at 8:08 AM
|Up 35%, this Baltimore company's stock is one of the biggest gainers in the U.S. today|
finance.yahoo.com - March 7 at 5:11 PM
|Why Autodesk, H&R Block, and Medifast Jumped Today|
finance.yahoo.com - March 7 at 5:11 PM
|Medifast (MED) Upgraded by Sidoti to "Buy"|
www.americanbankingnews.com - March 7 at 11:58 AM
|Medifast profit up 78% in 4Q; activist investor steps down from board|
finance.yahoo.com - March 7 at 9:41 AM
|Medifast (MED) Announces Quarterly Earnings Results, Beats Expectations By $0.12 EPS|
www.americanbankingnews.com - March 6 at 7:17 PM
|Medifast (MED) Updates FY18 Earnings Guidance|
www.americanbankingnews.com - March 6 at 5:12 PM
|Medifast (MED) Releases Q1 Earnings Guidance|
www.americanbankingnews.com - March 6 at 5:12 PM
|Medifast, Inc. Announces Fourth Quarter and Full Year 2017 Financial Results|
finance.yahoo.com - March 6 at 4:44 PM
|WINTON GROUP Ltd Takes Position in Medifast Inc (MED)|
www.americanbankingnews.com - March 6 at 3:31 PM
|Should You Buy Medifast Inc (NYSE:MED) For Its Dividend?|
finance.yahoo.com - March 6 at 9:25 AM
|Medifast's entry into Asia is first step in aggressive international expansion|
www.bizjournals.com - March 4 at 5:15 PM
|Medifast (MED) Upgraded to Buy at ValuEngine|
www.americanbankingnews.com - March 4 at 3:01 PM
|Medifast Inc (MED) Shares Bought by Bogle Investment Management L P DE|
www.americanbankingnews.com - March 4 at 4:57 AM
|Medifast to begin selling in Hong Kong and Singapore next year|
finance.yahoo.com - March 1 at 4:45 PM
|Martingale Asset Management L P Reduces Stake in Medifast Inc (MED)|
www.americanbankingnews.com - March 1 at 9:34 AM
|Medifast Announces Global Expansion with its Lifestyle Brand, OPTAVIA®|
finance.yahoo.com - February 28 at 9:29 AM
|EAM Investors LLC Acquires 25,831 Shares of Medifast Inc (MED)|
www.americanbankingnews.com - February 27 at 3:00 PM
|Systematic Financial Management LP Decreases Position in Medifast Inc (MED)|
www.americanbankingnews.com - February 27 at 11:28 AM
|Arrowstreet Capital Limited Partnership Has $13.24 Million Holdings in Medifast Inc (MED)|
www.americanbankingnews.com - February 27 at 4:34 AM
|Medifast (MED) Set to Announce Quarterly Earnings on Tuesday|
www.americanbankingnews.com - February 27 at 4:12 AM
|Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2017|
finance.yahoo.com - February 20 at 9:09 AM
|Medifast (MED) versus Simply Good Foods (SMPL) Financial Survey|
www.americanbankingnews.com - February 17 at 11:56 AM
|Contrasting Medifast (MED) & Simply Good Foods (SMPL)|
www.americanbankingnews.com - February 15 at 9:12 PM
|Medifast (MED) to Release Earnings on Wednesday|
www.americanbankingnews.com - February 14 at 2:56 AM
|Analyzing Medifast (MED) and Simply Good Foods (SMPL)|
www.americanbankingnews.com - February 11 at 1:12 AM
|Head-To-Head Analysis: Simply Good Foods (SMPL) and Medifast (MED)|
www.americanbankingnews.com - February 7 at 5:32 AM
|Head-To-Head Review: Simply Good Foods (SMPL) versus Medifast (MED)|
www.americanbankingnews.com - February 4 at 3:04 PM
|Critical Contrast: Medifast (MED) versus Simply Good Foods (SMPL)|
www.americanbankingnews.com - February 4 at 1:22 PM
|Analyzing Medifast (MED) & Simply Good Foods (SMPL)|
www.americanbankingnews.com - January 30 at 7:12 PM
|Simply Good Foods (SMPL) versus Medifast (MED) Critical Review|
www.americanbankingnews.com - January 30 at 11:06 AM
|Contrasting Simply Good Foods (SMPL) & Medifast (MED)|
www.americanbankingnews.com - January 29 at 5:14 PM
|Medifast (MED) and Simply Good Foods (SMPL) Financial Review|
www.americanbankingnews.com - January 26 at 5:06 AM
|Scott Burger, the man who helped bring Pandora HQ to city, leaving company|
www.bizjournals.com - January 18 at 9:44 AM
|OPTAVIA® Featured in PEOPLE's Annual Half Their Size Issue|
finance.yahoo.com - January 16 at 9:28 AM
|Medifast (MED) Upgraded at Zacks Investment Research|
www.americanbankingnews.com - January 13 at 10:54 AM
|Medifast (MED) Upgraded to "Buy" at Zacks Investment Research|
www.americanbankingnews.com - January 6 at 12:20 AM
|Top Ranked Income Stocks to Buy for December 26th|
finance.yahoo.com - December 26 at 2:42 PM
|Here's Why You Should Buy Medifast (MED) Stock Right Now|
www.zacks.com - December 23 at 5:14 AM
|Medifast, Inc. : MED-US: Dividend Analysis : December 22nd, 2017 (record date) : By the numbers : December 22, 2017|
finance.yahoo.com - December 23 at 5:14 AM
|Here's Why You Should Buy Medifast (MED) Stock Right Now|
finance.yahoo.com - December 22 at 9:32 AM
Medifast (NYSE:MED) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Medifast (NYSE:MED) Income Statement, Balance Sheet and Cash Flow Statement
Medifast (NYSE MED) Stock Chart for Wednesday, March, 21, 2018